Peptides control a vast range of intra- and intercellular processes. However, linear peptides suffer from instability and poor cell permeability, which limits their application as therapeutic agents. In contrast to linear peptides, cyclic variants are more resistant to both exo- and endoproteases, which explains the therapeutic potential of this class of molecules. Peptide macrocycles have shown remarkable capacity for functional fine-tuning.